Boan Biotech (06955.HK) Enters into a Promotion Cooperation Agreement with Nanjing Luye

Zhito Finance APP News: Boan Biotech (06955.HK) announced that on October 9, 2026, the Company entered into a promotion cooperation agreement with Nanjing Luye, a subsidiary of Luye Pharma (the controlling shareholder of the Company), pursuant to which Nanjing Luye will provide promotion and marketing services for the Company's designated products, with a term commencing on October 9, 2026 and ending on September 30, 2027.